These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7861705)

  • 1. Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients.
    Kitaoka M; Fukagawa M; Ogata E; Kurokawa K
    Kidney Int; 1994 Oct; 46(4):1110-7. PubMed ID: 7861705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients.
    Fukagawa M; Kitaoka M; Yi H; Fukuda N; Matsumoto T; Ogata E; Kurokawa K
    Nephron; 1994; 68(2):221-8. PubMed ID: 7830860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography.
    Tanaka R; Kakuta T; Fujisaki T; Tanaka S; Sakai H; Kurokawa K; Saito A
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii58-61. PubMed ID: 12771303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism.
    Malberti F; Corradi B; Cosci P; Calliada F; Marcelli D; Imbasciati E
    Am J Kidney Dis; 1996 Nov; 28(5):704-12. PubMed ID: 9158208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonographic intervention of parathyroid hyperplasia in chronic dialysis patients: a theoretical approach.
    Fukagawa M; Kitaoka M; Kurokawa K
    Nephrol Dial Transplant; 1996; 11 Suppl 3():125-9. PubMed ID: 8840327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism.
    Nakanishi S; Yano S; Nomura R; Tsukamoto T; Shimizu Y; Shin J; Fukagawa M
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii47-9. PubMed ID: 12771300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and medical treatment of secondary hyperparathyroidism.
    Fukagawa M; Kurokawa K
    Semin Surg Oncol; 1997; 13(2):73-7. PubMed ID: 9088062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients.
    Yamamoto H; Katoh N; Takeyama H; Ikeda M; Yokoyama K; Shigematsu T; Kawaguchi Y; Hosoya T
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii50-2. PubMed ID: 12771301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful ultrasonically guided percutaneous ethanol injection for secondary hyperparathyroidism.
    Takeda S; Michigishi T; Takazakura E
    Nephron; 1992; 62(1):100-3. PubMed ID: 1436272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients.
    Kakuta T; Fukagawa M; Fujisaki T; Hida M; Suzuki H; Sakai H; Kurokawa K; Saito A
    Am J Kidney Dis; 1999 Jun; 33(6):1091-9. PubMed ID: 10352197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism.
    Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
    Nephron Clin Pract; 2006; 102(1):c1-7. PubMed ID: 16166800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Percutaneous ethanol injections in the treatment of secondary hyperparathyroidism].
    Kuzdak K; Rybińska A; Białas M
    Endokrynol Pol; 2005; 56(6):891-6. PubMed ID: 16821207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous calcitriol therapy in an early stage prevents parathyroid gland growth.
    Taniguchi M; Tokumoto M; Tsuruya K; Hirakata H; Iida M
    Nephrol Dial Transplant; 2008 Nov; 23(11):3662-9. PubMed ID: 18515308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism.
    Koiwa F; Kakuta T; Tanaka R; Yumita S
    Nephrol Dial Transplant; 2007 Feb; 22(2):522-8. PubMed ID: 17127701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intervention for recurrent secondary hyperparathyroidism from a residual parathyroid gland.
    Yumita S
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii62-4. PubMed ID: 12771304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism.
    Fletcher S; Kanagasundaram NS; Rayner HC; Irving HC; Fowler RC; Brownjohn AM; Turney JH; Will EJ; Davison AM
    Nephrol Dial Transplant; 1998 Dec; 13(12):3111-7. PubMed ID: 9870475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.
    Lomonte C; Martino R; Selvaggiolo M; Bona RM; Cazzato F; Milano R; Chiarulli G; Basile C
    J Nephrol; 2003; 16(5):716-20. PubMed ID: 14733419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of weekly percutaneous maxacalcitol injection therapy in patients with secondary hyperparathyroidism.
    Saito A; Matsumoto Y; Oyama Y; Asaka M; Yokoyama H
    Ther Apher Dial; 2010 Feb; 14(1):98-103. PubMed ID: 20438525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia.
    Shiizaki K; Hatamura I; Negi S; Narukawa N; Mizobuchi M; Sakaguchi T; Ooshima A; Akizawa T
    Kidney Int; 2003 Sep; 64(3):992-1003. PubMed ID: 12911549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of intravenous calcitriol on the treatment of severe hyperparathyroidism, parathyroid gland mass and bone mineral density in haemodialysis patients.
    Huraib S; Abu-Aisha H; Abed J; Al Wakeel J; Al Desouki M; Memon N
    Am J Nephrol; 1997; 17(2):118-23. PubMed ID: 9096441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.